Corrigendum: Long non-coding RNAs as molecular biomarkers in cholangiocarcinoma

Front Cell Dev Biol. 2022 Nov 17:10:1090025. doi: 10.3389/fcell.2022.1090025. eCollection 2022.

Yanhua Wu¹, Khizar Hayat², Yufei Hu¹, Jianfeng Yang^{3

4}

¹ Department of Gastroenterology, The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
² Department of Gastroenterology, International Education College of Zhejiang Chinese Medical University, Hangzhou, China.
³ Department of Gastroenterology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
⁴ Key Laboratory of Integrated Traditional Chinese and Western Medicine for Biliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fcell.2022.890605.].

Keywords: biomarker; cholangiocarcinoma; diagnosis; lncRNA; prognosis; therapeutic target.